218 related articles for article (PubMed ID: 3613336)
1. [Evaluation of chemotherapy in advanced urothelial carcinoma: with special reference to combination chemotherapy with adriamycin, cyclophosphamide and cisplatin (ACE chemotherapy)].
Tobisu K; Matsumoto K; Takai K; Kakizoe T
Nihon Hinyokika Gakkai Zasshi; 1987 Feb; 78(2):327-34. PubMed ID: 3613336
[No Abstract] [Full Text] [Related]
2. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
3. Pre-cystectomy chemotherapy with sequentially administered cisplatin, cyclophosphamide and adriamycin in invasive transitional cell carcinoma of the bladder (preliminary report).
Guazzieri S; Sperandio P; Fandella A; Garbeglio A; Pegoraro V; Chiarion V; Fiorentino M; Pagano F
Prog Clin Biol Res; 1988; 260():599-602. PubMed ID: 3362909
[No Abstract] [Full Text] [Related]
4. [Aggressive preoperative chemotherapy in infiltrating bladder carcinoma with a combination of cisplatin, cyclophosphamide and adriamycin. Preliminary report].
Martínez-Piñeiro JA; de la Peña JJ; Hidalgo L; Cisneros J; Jiménez de León J; Machuca J
Arch Esp Urol; 1986; 39(1):33-46. PubMed ID: 3707210
[No Abstract] [Full Text] [Related]
5. [Chemotherapy for advanced bladder cancer: clinical evaluation of chemotherapy for locally advanced or metastatic bladder cancer and adjuvant chemotherapy for deeply invasive bladder cancer following radical cystectomy].
Uekado Y; Ogawa T; Yoshida T; Yamamoto S; Hirano A; Watanabe T; Shinka T; Ohkawa T
Hinyokika Kiyo; 1985 Aug; 31(8):1365-70. PubMed ID: 3841260
[TBL] [Abstract][Full Text] [Related]
6. [[Neoadjuvant chemotherapy (cisplatin, doxorubicin, cyclophosphamide) in the treatment of invasive urothelial tumors of the bladder. Preliminary results of a prospective study concerning 22 patients].
Trifard F; Chrétien Y; Vallantin X; Collet C; Lachand AT; Dufour B
Ann Urol (Paris); 1988; 22(3):216-9. PubMed ID: 3401004
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and pathological evaluations of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) chemotherapy for advanced urothelial cancers].
Takenaka A; Gotoh A; Hara I; Gohji K; Ogawa T; Arakawa S; Matsumoto O; Kamidono S; Hamami G; Itani A
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1909-15. PubMed ID: 2393308
[TBL] [Abstract][Full Text] [Related]
8. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.
Koch MO; Coussens D
Semin Urol; 1993 Feb; 11(1):14-9. PubMed ID: 8465122
[No Abstract] [Full Text] [Related]
9. Pre surgery chemotherapy in bladder cancer.
Francini M; Veronesi A; Dal Bo V; Carbone A; Monfardini S
Prog Clin Biol Res; 1988; 260():585-9. PubMed ID: 3362908
[No Abstract] [Full Text] [Related]
10. [Intra-arterial chemotherapy for locally advanced bladder cancer].
Aota Y; Yoshida K
Hinyokika Kiyo; 1999 Feb; 45(2):149-53. PubMed ID: 10212791
[TBL] [Abstract][Full Text] [Related]
11. Preoperative and postoperative adjuvant chemotherapy using CISCA (cyclophosphamide, doxorubicin, and cisplatin) in the treatment of invasive transitional-cell carcinoma of the bladder.
Lynch DF
Urol Clin North Am; 1991 Aug; 18(3):543-6. PubMed ID: 1877118
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy for bladder cancer: the MSKCC experience.
Fair WR; Scher H; Herr H; Morse M; Sogani P; Bosi G; Dershaw D; Reuter V; Curley T
Semin Urol; 1990 Aug; 8(3):190-6. PubMed ID: 2399387
[No Abstract] [Full Text] [Related]
13. [Chemotherapy for advanced urothelial cancer patients with a combination of low-dose consecutive cisplatin and etoposide].
Hashimoto H; Tokumitsu M; Morikawa M; Numata A; Yachiku S; Iuchi H; Yamauchi K
Gan To Kagaku Ryoho; 1996 Jun; 23(7):941-4. PubMed ID: 8678548
[No Abstract] [Full Text] [Related]
14. [Preliminary results of prophylactic adjuvant chemotherapy with CISCA in bladder tumors].
Bittard H
J Urol (Paris); 1988; 94(7):345-7. PubMed ID: 2464650
[TBL] [Abstract][Full Text] [Related]
15. [Effect of combination chemotherapy of tegafur, adriamycin and cisplatin on patients with advanced relapsing prostatic carcinoma and advanced bladder tumor].
Yoshida K; Nakame Y; Horiuchi S; Kaneoya F; Kuroda T; Tanoiri A; Koizumi M; Takahashi M; Negishi T; Saitoh H
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1083-5. PubMed ID: 3083786
[No Abstract] [Full Text] [Related]
16. [Combined therapy with 5-fluorouracil, doxorubicin, cis-diamminedichloroplatinum on advanced urothelial cancer].
Kawai T; Washizuka M; Kihara K; Takahashi T; Sakata Y; Tai K; Nagayama T; Okada K; Kusuyama H; Ishii Y
Nihon Gan Chiryo Gakkai Shi; 1987 Feb; 22(1):40-6. PubMed ID: 3611890
[No Abstract] [Full Text] [Related]
17. Therapeutic experience of advanced urothelial tract tumors.
Nakada T; Akiya T; Yoshikawa M; Umeda K; Katayama T
Hinyokika Kiyo; 1985 Apr; 31(4):601-6. PubMed ID: 4041118
[TBL] [Abstract][Full Text] [Related]
18. Combined intravenous and intra-arterial cyclophosphamide, doxorubicin, and cisplatin (CISCA) in the management of select patients with invasive urothelial tumors.
Logothetis CJ; Samuels ML; Selig DE; Wallace S; Johnson DE
Cancer Treat Rep; 1985 Jan; 69(1):33-8. PubMed ID: 2981619
[TBL] [Abstract][Full Text] [Related]
19. [Systemic chemotherapy in advanced bladder cancer. New aspects].
Jakse G
Wien Klin Wochenschr; 1987 Jan; 99(2):54-7. PubMed ID: 3564487
[TBL] [Abstract][Full Text] [Related]
20. [Polychemotherapy treatment with cisplatin, adriamycin, 5-fluorouracil (FAP) and cisplatin, adriamycin and cyclophosphamide (CISCA) in advanced transitional carcinoma of the bladder].
Sánchez Romero JA; Ramírez Ruiz F; Romero Fernández L; Pastor Gaitán P; Murillo Capitán E
Actas Urol Esp; 1989; 13(4):240-2. PubMed ID: 2678934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
